United States Pharmaceuticals

Fougera Pharmaceuticals Inc (BDY)

Track

Ticker: BDY
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
GLASSMAN BRADLEY Senior VP - Sales & Marketing Officer
Transaction date
Purchase
Price
227.97
Quantity 55,627 +24.1%
Value US$3,436,917
JACOB LEONARD S Non-Executive Director
Transaction date
Purchase
Price
494.78
Quantity 49,487 -28.9%
Value US$1,425,749
HAMOT SETH W Non-Executive Director Large shareholder
Transaction date
Purchase
Price
179.82
Quantity 52,441 +46.9%
Value US$4,570,196
Costa Brava Partnership III LP Large shareholder
Transaction date
Purchase
Price
20.44
Quantity 5,000 +0.3%
Value US$102,185
Costa Brava Partnership III LP Large shareholder
Transaction date
Purchase
Price
20.00
Quantity 5,000 +0.3%
Value US$100,009
HAMOT SETH W Non-Executive Director Large shareholder
Transaction date
Purchase
Price
20.00
Quantity 5,000 +0.3%
Value US$100,009
Costa Brava Partnership III LP Large shareholder
Transaction date
Purchase
Price
20.07
Quantity 5,000 +0.3%
Value US$100,335
HAMOT SETH W Non-Executive Director Large shareholder
Transaction date
Purchase
Price
20.07
Quantity 5,000 +0.3%
Value US$100,335
HAMOT SETH W Non-Executive Director Large shareholder
Transaction date
Purchase
Price
20.00
Quantity 5,000 +0.3%
Value US$99,988
Costa Brava Partnership III LP Large shareholder
Transaction date
Purchase
Price
20.00
Quantity 5,000 +0.3%
Value US$99,988
GLASSMAN DANIEL Chairman, Pres. & CEO Executive Director Large shareholder
Transaction date
Sale
Price
25.35
Quantity 2,000 -12.5%
Value US$50,700
GOLDSTEIN ALAN S VP - Corporate Development Officer
Transaction date
Purchase
Price
25.19
Quantity 204 +48.7%
Value US$5,139
LANDAU RALPH N VP - Manufacturing Officer
Transaction date
Purchase
Price
25.19
Quantity 400 +95.5%
Value US$10,076
GLASSMAN BRADLEY VP - Marketing Officer
Transaction date
Purchase
Price
25.19
Quantity 1,053 +3.9%
Value US$26,525
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2007-05-10 2007-05-07 B Purchase GLASSMAN BRADLEY

Senior VP - Sales & Marketing

Officer
55,627 +24.1%
227.97
US$3,436,917 		55,627 +24.1% 227.97 US$3,436,917
2007-05-02 2007-03-30 B Purchase JACOB LEONARD S Non-Executive Director
49,487 -28.9%
494.78
US$1,425,749 		49,487 -28.9% 494.78 US$1,425,749
2006-11-30 2006-11-28 B Purchase HAMOT SETH W Non-Executive Director Large shareholder
52,441 +46.9%
179.82
US$4,570,196 		52,441 +46.9% 179.82 US$4,570,196
2006-11-30 2006-11-28 B Purchase Costa Brava Partnership III LP Large shareholder
5,000 +0.3%
20.44
US$102,185 		5,000 +0.3% 20.44 US$102,185
2006-11-29 2006-11-27 B Purchase Costa Brava Partnership III LP Large shareholder
5,000 +0.3%
20.00
US$100,009 		5,000 +0.3% 20.00 US$100,009
2006-11-29 2006-11-27 B Purchase HAMOT SETH W Non-Executive Director Large shareholder
5,000 +0.3%
20.00
US$100,009 		5,000 +0.3% 20.00 US$100,009
2006-11-28 2006-11-24 B Purchase Costa Brava Partnership III LP Large shareholder
5,000 +0.3%
20.07
US$100,335 		5,000 +0.3% 20.07 US$100,335
2006-11-28 2006-11-24 B Purchase HAMOT SETH W Non-Executive Director Large shareholder
5,000 +0.3%
20.07
US$100,335 		5,000 +0.3% 20.07 US$100,335
2006-11-27 2006-11-22 B Purchase HAMOT SETH W Non-Executive Director Large shareholder
5,000 +0.3%
20.00
US$99,988 		5,000 +0.3% 20.00 US$99,988
2006-11-27 2006-11-22 B Purchase Costa Brava Partnership III LP Large shareholder
5,000 +0.3%
20.00
US$99,988 		5,000 +0.3% 20.00 US$99,988
2004-06-16 2004-06-14 S Sale GLASSMAN DANIEL

Chairman, Pres. & CEO

Executive Director Large shareholder
2,000 -12.5%
25.35
US$50,700 		2,000 -12.5% 25.35 US$50,700
2004-03-29 2004-03-23 B Purchase GOLDSTEIN ALAN S

VP - Corporate Development

Officer
204 +48.7%
25.19
US$5,139 		204 +48.7% 25.19 US$5,139
2004-03-29 2004-03-10 B Purchase LANDAU RALPH N

VP - Manufacturing

Officer
400 +95.5%
25.19
US$10,076 		400 +95.5% 25.19 US$10,076
2004-03-29 2004-03-10 B Purchase GLASSMAN BRADLEY

VP - Marketing

Officer
1,053 +3.9%
25.19
US$26,525 		1,053 +3.9% 25.19 US$26,525
Explore more

More insider trading research around Fougera Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America